- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketMarket MoversStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare SBI Healthcare Opportunities Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 5.0 | 4.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.93 | 1.89 |
NAV | ₹437.48 | ₹40.07 |
Fund Started | 04 Jun 1999 | 25 Jun 2018 |
Fund Size | ₹3689.28 Cr | ₹5507.52 Cr |
Exit Load | Exit load of 0.50% if redeemed within 15 days | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
5.0
4.0
Min SIP Amount
₹500
₹100
Expense Ratio
1.93
1.89
NAV
₹437.48
₹40.07
Fund Started
04 Jun 1999
25 Jun 2018
Fund Size
₹3689.28 Cr
₹5507.52 Cr
Exit Load
Exit load of 0.50% if redeemed within 15 days
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 20.59% | 20.98% |
3 Year | 29.70% | 30.30% |
5 Year | 24.66% | 24.91% |
1 Year
20.59%
20.98%
3 Year
29.70%
30.30%
5 Year
24.66%
24.91%
Holding Analysis
Equity | 96.09% | 96.99% |
Cash | 3.83% | 3.01% |
Equity
96.09%
96.99%
Cash
3.83%
3.01%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.73% |
Divi's Laboratories Ltd. | 7.39% |
Max Healthcare Institute Ltd. | 6.40% |
Lonza Group Ag | 4.81% |
Cipla Ltd. | 4.77% |
Lupin Ltd. | 4.46% |
Mankind Pharma Ltd. | 3.75% |
Krishna Institute of Medical Sciences Ltd | 3.34% |
Fortis Healthcare Ltd. | 3.22% |
Acutaas Chemicals Ltd. | 3.19% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.66% |
Dr. Reddy's Laboratories Ltd. | 9.66% |
Divi's Laboratories Ltd. | 9.03% |
Cipla Ltd. | 7.85% |
Aurobindo Pharma Ltd. | 6.34% |
Alkem Laboratories Ltd. | 4.12% |
Zydus Lifesciences Ltd. | 4.01% |
Lupin Ltd. | 3.98% |
Gland Pharma Ltd. | 3.95% |
Syngene International Ltd. | 2.46% |
Fund Manager
Name | Tanmaya Desai | Dharmesh Kakkad |
Start Date | 27 Jun 2011 | 23 Feb 2021 |
Name
Tanmaya Desai
Dharmesh Kakkad
Start Date
27 Jun 2011
23 Feb 2021
About Fund
Description | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 04 Jun 1999 | 25 Jun 2018 |
Description
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Jun 1999
25 Jun 2018